Table I: Baseline characteristics of the subjects in the sitagliptin and alogliptin groups


 

sitagliptin

alogliptin

p-values


age (years old)

53.5+11.5

50.0+12.9

n.s.

sex (F/M)

7/30

4/31

n.s.

FBS (mg/dl)

226.1+64.6

221.4+53.7

n.s.

HbA1c (%)

10.43+2.21

10.40+2.08

n.s.

T-C (mg/dl)

227.1+42.2

240.8+40.8

n.s.

TG (mg/dl)

231.6+222.0

209.0+220.0

n.s.

HDL-C (mg/dl)

52.4+12.5

52.4+17.9

n.s.

nonHDL-C (mg/dl)

174.6+41.3

188.4+41.0

n.s.

LDL-C (mg/dl)

147.7+32.2

155.9+52.4

n.s.

FFA (eEq/l)

0.957+0.333

0.808+0.300

n.s.

UA (mg/dl)

5.11+1.42

4.81+1.47

n.s.

insulin (µU/ml)

6.86+4.52

8.03+6.02

n.s.

HOMA-R

3.79+2.91

4.48+3.51

n.s.

HOMA-B

18.33+15.59

20.26+20.00

n.s.

BMI

25.22+4.63

26.51+5.84

n.s.


Kutoh et al.Journal of Diabetes Research and Clinical Metabolism  2012 1:17DOI : 10.7243/2050-0866-1-17